SYK
★★☆☆☆ PasstemplateStryker Corporation
Healthcare · sector percentile 91
Session move
$278.20
Vol 0.93× avg
64/100 quant · tgt $365.80
RS60 -20.1% vs SPY · ADV$ 843.0M
session 2026-10-06 · Snapshot — not live tape
Since last scan
2026-10-06 → 2026-10-07
Context only — not a buy/sell signal. Built from scan history and cached news/filings.
Snapshot quote
session 2026-10-06 · scan 2026-10-07 · pushed 10-07 13:34 ET · Regular session (stale)
Show quote fundamentalsHide quote fundamentals
- Last (scan/close)
- $277.73
- Previous close
- $285.22
- Pushed last
- $278.90 (stale) · 10-07 13:34 ET · Regular session
- Session open
- $279.37
- Last session range
- $277.10 – $284.53
- 52-week range
- $267.00 – $389.48
- Session volume
- 2,820,701
- Avg volume (20d)
- 3,047,990
- Market cap
- $106.53B
- PE (TTM)
- 28.78
- Forward PE
- 16.61
- Dividend yield
- 1.25%
- 1y target est.
- $365.80
- Next earnings
- 2026-10-29
Snapshot quote — last daily session bars and scan fundamentals. Not live bid/ask or intraday quotes.
If you put $1,000.00 in
1y ago
$759.38
−24%
5y ago
$1,108.69
+11%
Price path only from cached daily closes (adjusted when available). Not dividends cash, fees, or advice.
Market briefing
Curated digest — not a trade signal. Headlines and links as provided by the producer.
- The Bottom Fishing Club - Embecta: Excellent Turnaround Prospect In Defensive Medical Products
Embecta (EMBC) looks like a deep value buy: P/E under 3x, 50%+ FCF yield, insider buying and rebound setup.
SeekingAlpha · 2026-08-25
- How Much More Can Boston Scientific Stock Move After Losing Half Its Value?
Options price a band whose floor sits below anything the stock has touched in the past year, and the company's own recovery timetable lands after that window closes.
Yahoo · 2026-08-13
- Can Stryker's Q2 Recovery and Guidance Support a Stronger Second Half?
Stryker enters the second half with Q2 momentum restored, but meeting guidance hinges on production, backlog conversion and managing cyber and supply risks.
Yahoo · 2026-08-13
Price Chart
Daily prices from cache
Loading price history…
AI Analysis
- Bull Thesis — SYK scores 64.16/100 (Pass) with revenue growth at 9.4% and a multi-factor profile supporting the current ranking.
- Risks — Key risks for SYK include valuation compression, sector rotation, and any deterioration in earnings momentum or balance-sheet leverage. Context: cached next earnings 2026-10-29; cached 8-K filed 2026-10-06; cached Form 4 cluster (count, n=2, latest 2026-09-28); disclosure reasons form4_cluster_ambiguous, item_5_02.
- Target Upside — Consensus implied upside is 31.7%. Category 'Pass' suggests monitoring position sizing against the 100-point model thresholds.
Score History
30 days of scans. Daily batch adds the next weekday automatically while the API is running.
- DatePriceChgScoreRating
- 2026-10-07$277.73−$5.6764.2Pass
- 2026-10-06$283.40+$0.8664.2Pass
- 2026-10-05$282.54+$9.3364.2Pass
- 2026-10-02$273.21−$0.2264.2Pass
- 2026-10-01$273.42−$0.2364.2Pass
- 2026-09-30$273.65−$3.5864.2Pass
- 2026-09-29$277.23+$5.2564.2Pass
- 2026-09-28$271.99+$0.4764.2Pass
- 2026-09-25$271.52−$1.8764.2Pass
- 2026-09-24$273.39+$0.7864.6Pass
- 2026-09-23$272.61−$3.2964.6Pass
- 2026-09-22$275.90+$2.7064.4Pass
- 2026-09-21$273.20−$4.7464.2Pass
- 2026-09-18$277.94−$5.7864.4Pass
- 2026-09-17$283.72−$2.3066.0Pass
- 2026-09-16$286.01+$7.1465.0Pass
- 2026-09-15$278.87−$6.5864.5Pass
- 2026-09-14$285.45+$17.6164.5Pass
- 2026-09-11$267.84−$5.5564.2Pass
- 2026-09-10$273.39−$3.1464.2Pass
- 2026-09-09$276.53−$26.6064.2Pass
- 2026-09-08$303.13$0.0067.2Pass
- 2026-09-07$303.13−$4.8667.2Pass
- 2026-09-04$307.99−$4.2068.3Pass
- 2026-09-03$312.19−$7.6369.5Pass
- 2026-09-02$319.82−$3.9871.3Watch
- 2026-09-01$323.80−$6.8970.2Watch
- 2026-08-31$330.69+$4.9270.2Watch
- 2026-08-28$325.78−$3.9070.2Watch
- 2026-08-27$329.67—69.9Pass
Quant Breakdown
Short volume (FINRA)
Off-exchange short sale volume ratio vs recent sessions — not a squeeze forecast.
- Short / total
- 57.5%
- vs 20d (z)
- 1.00
- Short vol
- 751,473
- Status
- ok
Squeeze pressure score
full33/100
- Short leg
- 39
- Call leg
- 32
- Activity
- 1.6
- Call vol share
- 9.3%
- PCR (vol)
- 9.76
- Call OI share
- 60.8%
- ATM IV
- 35.5%
FINRA off-exchange short volume (TRF/ADF consolidated). Not short interest as % of float. Squeeze pressure score (0–100) — free composite of off-exchange short volume and (when available) call-side options activity. Not a probability that a squeeze will occur.
Disclosure score
Rule-based News / Insider / Earnings legs from cached SEC filings — context only, not beat/miss or a buy signal.
Disclosure score
-12
- News
- -12
- Insider
- 0
- Earnings
- 0
Signals below are rule hits from cached filings — Risk / Constructive / Attention. Attention is not a bullish call. Linked chips open the SEC original when available.
Attention (~)
Disclosure event score — rule-based view of recent SEC filings and earnings calendar. Not a prediction that price will move, and not earnings beat/miss.
Earnings surprise (quant context)
From Yahoo/public fundamentals cached on the last quant scan — not part of the disclosure event score, and not a buy signal. Figure can lag the latest print.
Last reported surprise +0.4%
Filings & events
Recent SEC disclosures and earnings dates — context only, not a trade signal.
- Next earnings
- 2026-10-29yahoo_calendar
- Last earnings
- —
- SEC ↗8-K2026-10-06
8-K
- SEC ↗42026-09-28
FORM 4
- SEC ↗42026-09-24
FORM 4
- SEC ↗42026-09-02
FORM 4
- SEC ↗42026-08-26
FORM 4
- SEC ↗42026-08-20
FORM 4
- SEC ↗42026-08-18
FORM 4
- SEC ↗42026-08-04
FORM 4
- SEC ↗42026-08-04
FORM 4
- SEC ↗42026-08-04
FORM 4
SEC filings as reported; earnings dates may come from Yahoo calendar. Context only — not investment advice and not a prediction that price will move on a filing or event.